Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
批准号:
10683922
负责人:
Thomas Louis LaFramboise
金额:
$36.09万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-08-31
关键词:
3-DimensionalAffectApoptosisAutomobile DrivingBiological MarkersCancer EtiologyCellsCessation of lifeChromatinClustered Regularly Interspaced Short Palindromic RepeatsColonColon CarcinomaColonic NeoplasmsComplexDNADataDiseaseEpitheliumGene ExpressionGene Expression RegulationGenesGenomicsGoalsHealthHumanImmunodeficient MouseKRAS2 geneKnock-outLaboratoriesMADH4 geneMalignant NeoplasmsMediatingMolecularMutationNMR SpectroscopyNuclearOncogenesOncogenicOrganoidsPatientsPhenotypePlayProcessProliferatingProteinsRNA BindingRecurrenceRoleSiteStructureTP53 geneTestingThe Cancer Genome AtlasTissuesTreatment FailureTumor Cell LineUnited StatesUntranslated RNAUp-RegulationValidationWorkXenograft ModelXenograft procedurecancer cellcancer typechromatin isolation by RNA purification sequencingcohortcolon cancer cell linecolon tumorigenesisexperimental studygenome-widegenomic locusin vivoknock-downnew therapeutic targetnovelnovel therapeuticsoverexpressionprotein complexrecruittargeted treatmenttherapeutic RNAtranscriptome sequencingtumortumor microenvironment
中文摘要
派:哈利勒,艾哈迈德
技术摘要:
结肠癌是美国癌症相关死亡的第二大原因,在很大程度上
由于治疗失败和复发频繁。最近的研究,包括我们的工作
实验室已经证明,受调控的长基因间非编码RNA(LincRNAs)是
在结肠肿瘤发生过程中的主要参与者,并可能成为新的治疗方法
目标。在本方案中,我们鉴定了一种新的lincRNA并对其进行了功能鉴定,
被称为lincDUSP,在结肠癌细胞中发挥致癌作用。击倒
LincDUSP显著消除肿瘤表型,包括抑制增殖和
集落形成,细胞凋亡率增加。这些研究还表明,lincDUSP
通过直接与染色质相互作用调节大量基因,并潜在地招募
蛋白质复合体到特定的基因组位置。在这项建议的目标1中,我们将进一步测试
利用异种移植模型研究lincDUSP在体内的致癌作用,并评估其作用。
LincDUSP在使用3D有机化合物推动结肠肿瘤发生中的作用。在目标2中,我们将调查
通过评估lincDUSP在基因调控中的作用来探讨其分子机制,并对其进行了表征
LincDUSP致癌活性所需的蛋白质复合体。最后,我们将
确定促进其与DNA相互作用的lincDUSP的二级结构
蛋白质。拟议研究的完成可能导致将lincDUSP作为一种小说
致癌lincRNA对结肠癌的发生有直接影响,并可能成为
心理治疗。
英文摘要
PI: Khalil, Ahmad
Technical Abstract:
Colon cancer is the second leading cause of cancer-related death in the United States, largely
due to frequent treatment failure and recurrence. Recent studies, including work from our
laboratory, have demonstrated that regulatory long intergenic non-coding RNAs (lincRNAs) are
major players in the process of colon tumorigenesis, and could emerge as novel therapeutic
targets. In this proposal, we have identified and functionally characterized a novel lincRNA,
referred to as lincDUSP, that exerts an oncogenic effect in colon cancer cells. Knockdown of
lincDUSP significantly abrogates the tumor phenotype, including decreased proliferation and
colony formation, and increased apoptosis. These studies have also revealed that lincDUSP
regulates numerous genes by directly interacting with chromatin, and potentially recruiting
protein complexes to specific genomic loci. In aim 1 of this proposal, we will further test the
oncogenic function of lincDUSP in vivo using a xenograft model, and also assess the role of
lincDUSP in driving colon tumorigenesis using 3D organoids. In aim 2, we will investigate the
molecular mechanisms of lincDUSP by assessing its role in gene regulation, and characterize
the protein complexes that are required for lincDUSP oncogenic activity. Lastly, we will
determine the secondary structure of lincDUSP that facilitates its interaction with DNA and
proteins. The completion of the proposed studies could lead to establishing lincDUSP as a novel
oncogenic lincRNA with direct impact on colon tumorigenesis, and possibly as a target for
therapy.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.
缺失5Q产生的分子特征的病理生理和临床意义。
DOI:
10.1016/j.ebiom.2022.104059
发表时间:
2022-06
期刊:
EBioMedicine
影响因子:
11.1
作者:
[Adema V, Palomo L, Walter W, Mallo M, Hutter S, La Framboise T, Arenillas L, Meggendorfer M, Radivoyevitch T, Xicoy B, Pellagatti A, Haferlach C, Boultwood J, Kern W, Visconte V, Sekeres M, Barnard J, Haferlach T, Solé F, Maciejewski JP]
通讯作者:
Maciejewski JP
DOI:
10.1038/s41467-022-28678-x
发表时间:
2022-02-24
期刊:
Nature communications
影响因子:
16.6
作者:
[Woerner J, Huang Y, Hutter S, Gurnari C, Sánchez JMH, Wang J, Huang Y, Schnabel D, Aaby M, Xu W, Thorat V, Jiang D, Jha BK, Koyuturk M, Maciejewski JP, Haferlach T, LaFramboise T]
通讯作者:
LaFramboise T
Integrative Systems Biology Core
-
批准号:10713944
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2023
-
负责人:Thomas Louis LaFramboise
-
依托单位:
Integrating Clues from the Somatic Genome in the Search for Rare Germline Cancer Susceptibility Variants
-
批准号:10159876
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2020
-
负责人:Thomas Louis LaFramboise
-
依托单位:
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
-
批准号:10232150
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2018
-
负责人:Thomas Louis LaFramboise
-
依托单位:
Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
-
批准号:10623378
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2017
-
负责人:Thomas Louis LaFramboise
-
依托单位:
Core 2: Biostatistics and Informatics Core
-
批准号:10227751
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2011
-
负责人:Thomas Louis LaFramboise
-
依托单位:
A genomic survey of allele-specific selection in tumor amplicons
-
批准号:7880064
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2008
-
负责人:Thomas Louis LaFramboise
-
依托单位:
A genomic survey of allele-specific selection in tumor amplicons
-
批准号:7687397
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2008
-
负责人:Thomas Louis LaFramboise
-
依托单位:
A genomic survey of allele-specific selection in tumor amplicons
-
批准号:7527126
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2008
-
负责人:Thomas Louis LaFramboise
-
依托单位:
A genomic survey of allele-specific selection in tumor amplicons
-
批准号:8113868
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2008
-
负责人:Thomas Louis LaFramboise
-
依托单位:
海外基金